Vigmed signs exclusive distribution agreement for the Belgian market
Vigmed announced today that they have signed an exclusive distribution agreement for another important market in Europe – Belgium - where Hospithera, part of the US Mylan Inc. Group, will be Vigmed’s distribution partner.
Following previous announcements of signed agreements for other European markets, Vigmed is now adding Belgium to their network of distributors for their unique and patented safety products.
“We welcome Hospithera to our expanding network of qualified and well renowned distributors, and we very much look forward to introducing our safety products to the Belgian market”, says Vigmed Sales Director, Mike Dooley. “Belgium is an important and rapidly growing market. I am confident that the synergy between our products and the high quality ones in the Hospithera range will ensure success for both companies.”
“After a thorough market analysis, we noticed that Vigmed’s catheters were received enthusiastically by the Belgian market. The safety of health professionals remains a hot topic, now - and in the future. We see great potential for our cooperation with Vigmed”, says Hospithera Interventional Care Division Manager, Jurgen Struylaart.
For further information contact:
CEO, Finn Ketler +46 42 600 5311 or Director Marketing and Sales, Mike Dooley +46 42 600 5317
Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market patented, needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has 20 employees. Vigmed’s share is traded on NASDAQ OMX First North Premier in Stockholm (ticker VIG) and has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor.
Additional information about the company can be found on Vigmed’s website: www.vigmed.com/investor